Biotech startup developing therapies that match molecules in human milk withdraws IPO filing geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
Progenity Announces Poster Presentations at Digestive Disease Week 2021
Two Abstracts Support Company’s Targeted Therapeutics Program including the Drug Delivery System
May 24, 2021 07:30 ET | Source: Progenity, Inc. Progenity, Inc. San Diego, California, UNITED STATES
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted Therapeutics program presented at the 2021 Digestive Disease Week® (DDW) Virtual Event. The posters include a preclinical study evaluating treatment of intestinal inflammation with the Company’s PGN-600 (liquid tofacitinib) product candidate and a second preclinical study of its investigational ingestible Drug Delivery System (DDS). DDW is the world’s premier meeting for physicians, researchers, and industry in the fields of gastroenterology, hepatology, endoscopy
Utah reports 15 more COVID-19 deaths msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.